Artiva Biotherapeutics, Inc. (ARTV)
NASDAQ: ARTV · Real-Time Price · USD
9.62
+0.79 (8.95%)
At close: Jun 26, 2026, 4:00 PM EDT
9.26
-0.36 (-3.74%)
After-hours: Jun 26, 2026, 7:37 PM EDT
Artiva Biotherapeutics Stock Forecast
Stock Price Forecast
The 5 analysts with 12-month price forecasts for Artiva Biotherapeutics stock have an average target of 35.8, with a low estimate of 23 and a high estimate of 41. The average target predicts an increase of 272.14% from the current stock price of 9.62.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Artiva Biotherapeutics stock from 6 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 | Jun '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 5 | 5 | 5 | 5 | 5 | 5 |
| Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 6 | 6 | 6 | 6 | 6 | 6 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| H.C. Wainwright | H.C. Wainwright | Buy Maintains $35 | Buy | Maintains | $35 | +263.83% | Jun 8, 2026 |
| Needham | Needham | Buy Reiterates $41 | Buy | Reiterates | $41 | +326.20% | Jun 8, 2026 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Maintains $40 | Buy | Maintains | $40 | +315.80% | May 26, 2026 |
Unknown Analyst Jefferies No rating | Jefferies | Buy Maintains $19 → $23 | Buy | Maintains | $19 → $23 | +139.09% | May 21, 2026 |
| Wedbush | Wedbush | Buy Maintains $40 | Buy | Maintains | $40 | +315.80% | May 21, 2026 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.43
from -3.43
EPS Next Year
-2.82
from -2.43
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | n/a | n/a | |
| Avg | n/a | n/a | |
| Low | n/a | n/a |
Revenue Growth
| Revenue Growth | 2027 | 2028 |
|---|---|---|
| High | - | - |
| Avg | - | - |
| Low | - | - |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | -2.18 | -2.47 | |
| Avg | -2.43 | -2.82 | |
| Low | -2.67 | -3.50 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | - | |
| Avg | - | - | |
| Low | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.